L egionnaires' disease is the designation for pneumonia caused by the Legionella species. In addition to its pulmonary involvement, Legionella has been isolated in the heart, brain, lymph nodes, spleen, liver, and kidneys in autopsy studies. Extrapulmonary manifestations are rare; of these, cardiac involvement is most prevalent, in the forms of myocarditis, pericarditis, postcardiotomy syndrome, and prosthetic valve endocarditis.1,2 Reported arrhythmias include bradycardia, tachycardia, and conduction abnormalities.3-5 The severity of the illness depends on the organ systems involved; it is typically severe with cardiac involvement, especially in myocarditis.We report the case of a patient who had Legionella myocarditis associated with acute left ventricular (LV) dysfunction and repolarization abnormalities, and we describe his treatment with use of a TandemHeart ® percutaneous ventricular assist device (pVAD) (CardiacAssist, Inc.; Pittsburgh, Pa). In addition, we review the medical literature on Legionella myocarditis and focus on cardiac outcomes.
Case ReportIn April 2013, a 48-year-old previously healthy man presented at a hospital with a 10-day history of cough, subjective fever, chills, myalgias, and generalized body aches. He was instructed to take oral antibiotics. However, he was readmitted the same night with worsening dyspnea, headaches, and hypoxemic respiratory failure that necessitated intubation. A chest radiograph and computed tomographic scans of the chest revealed extensive multilobar alveolar consolidation within the right lung (Fig. 1). Legionella infection was diagnosed on the basis of a positive urine antigen test. All other microbiological tests were negative, including bronchoalveolar lavage (gram stain, bacterial and viral cultures, and acid-fast bacilli) and Streptococcus pneumoniae urine antigen. Multiple viral studies were also negative: human immunodeficiency virus, parvovirus, Coxsackievirus A and B, influenza, and herpes simplex virus 1 and 2. Despite broad-spectrum antibiotic therapy that included levofloxacin and azithromycin, the patient's condition rapidly deteriorated, and his clinical course was complicated by acute renal and heart failure. A transthoracic echocardiogram (TTE) revealed dilated cardiomyopathy with severely depressed LV systolic function and severe mitral regurgitation. The patient's LV internal dimensions in systole and diastole were 4.8 cm and 5.8 cm, respectively. The estimated LV ejection fraction (LVEF) was 0.10. Cardiac biomarkers were noted to be positive. The patient then developed atrial flutter with variable atrioventricular block ( Fig. 2A), followed by